Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk model
Eur J Endocrinol. 2025 Jan 6;192(1):15-24. doi: 10.1093/ejendo/lvae166. ABSTRACT OBJECTIVE: We have shown that men aged 50 years+ at high risk of type 2 diabetes treated with testosterone together with a lifestyle program reduced the risk of type 2 diabetes at 2 years by 40% compared to a lifestyle program alone. To develop a personalized … Read more